About Us
Our Story
Team
Careers
News
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Select specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Confirm Password
AF and Heart Failure: What’s the Risk? Is Ablation the Answer?
By
Northwestern Medicine: 8th Annual Cardiovascular Update
FEATURING
Jonathan Piccini
August 14, 2019
0 Comments
Login to view comments.
Click here to Login
Featured Video
08:43
Boehringer Ingelheim and Lilly Cardiology
Considerations for Initiating a SGLT2 Inhibitor in Heart Failure Pat…
Feat.
J. Butler
Featured Video
10:26
Boehringer Ingelheim and Lilly Cardiology
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Rev…
Feat.
J. Butler
Related Content
AUTOPLAY
ON
Boston Scientific
Biophysics of Ablation – Fundamentals and Myths
Fri, Jun 26, 2020
Faculty:
Roderick Tung
,
Boston Scientific
,
David Haines
Boston Scientific
Incorporating Local Impedance Into Your RF Ablation Practice
Mon, Sep 14, 2020
Faculty:
Roderick Tung
,
Boston Scientific
,
Suraj Kapa
,
Christian Meyer
Boston Scientific
New Approaches to AF Ablation: Innovations in PFA, Cryo, and RF
Tue, Dec 6, 2022
Faculty:
Wilber Su
,
Boston Scientific
,
Moloy Das
,
Boris Schmidt
11:37
ACC 2022 Conference Coverage
ACC 2022: An Embarrassment of Riches - Updated Guideline Recommendat…
Feat.
P. Heidenreich
51:47
Boston Scientific
Biophysics of Ablation – Fundamentals and Myths
Feat.
R. Tung,
D. Haines
13:07
Michelle Kittleson
2021 ADA Highlights: Heart Failure With Reduced Ejection Fraction - …
18:36
The Texas Heart Institute
Rhythm vs Rate: Has the Tide Changed Since the AFFIRM Trial?
Feat.
M. Razavi
19:30
ACC 2022 Conference Coverage
Hot Topics in Heart Failure ACC.22
Feat.
N. Ibrahim
28:59
AtriCure
Hybrid Atrial Fibrillation Ablation: Addressing the Persistent and L…
Feat.
F. Yang
10:13
AtriCure
Cardiologist Perspective on Treatment of LSP AF
Feat.
V. Nguyen
10:25
AtriCure
EP Nurse Coordinators Role in a Hybrid Program
Feat.
M. Mech
22:46
AtriCure
CONVERGE Trial Results: Level 1 Superiority Data of Hybrid AF™ Conve…
Feat.
D. Lurgio
38:58
MUSC Cardiology
Inotropic Treatment for HFpEF? An Idea So Crazy It Just Might Be Rig…
Feat.
S. Litwin
21:36
NYU Langone
Emerging Therapies in Cardiac Amyloidosis
Feat.
M. Hanna
04:50
AtriCure
Discussion on Advanced Atrial Fibrillation: What Is It and How To Tr…
44:29
Houston Methodist DeBakey Heart and Vascular Center
Pathobiology, Clinical Relevance and the Future of Myocardial Recove…
Feat.
A. Bhimaraj
15:02
American College of Cardiology
ESC Congress 2022: DANCAVAS, REVIVED-BCIS2, ADVOR, ALL-HEART, and DE…
Feat.
D. Bhatt,
P. Gabriel Steg,
P. Kohli
12:23
American Heart & Vascular Institute
SGLT2 Inhibitors for HF: Is this Therapy Helpful for Reducing the Ho…
Feat.
M. Tipton
22:38
Scripps Health
Clinical Presentation of Amyloidosis: Who to Suspect? - a 2022 Update
Feat.
R. Mohan
14:44
26th Annual San Diego Heart Failure Symposium
Broadening Indications for the Use of Angiotensin Receptor Neprilysi…
Feat.
C. Yancy
17:35
San Diego Heart Failure Symposium for Primary Care and Internal Medicine Physicians
Recognizing and Treating HFpEF: How Helpful Are MRAs, ARNi and SGLT2…
Feat.
B. Greenberg
03:36
AtriCure
Discussion on Advanced Atrial Fibrillation: Why Hybrid AF™ Therapy a…
15:32
10th Annual California Heart Rhythm Symposium
Ablation of Persistent AF – What to Do Beyond PV Isolation?
